PCSK9 Inhibitors in Diabetes, Tirzepatide’s Cardiorenal Effects, Shingles Vaccine, and More From ACC

Key Points

• To discuss the implications of recent medical interventions on diabetes and cardiovascular health.
• Interview with Katie Berlacher, MD, MS
• Overview of key topics from the American College of Cardiology conference
• Highlights of relevant medical news and advancements
• Introduction of PCSK9 inhibitors as a notable advancement
• Discussion on tirzepatide's benefits for cardiorenal health
• Emphasis on the shingles vaccine as an important preventive measure